Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Hirsh

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
Archives of Internal Medicine|October 20, 2017
Heparin Side Effects-ReplyRussell Hull, Jack Hirsh
Lancet (London, England)|April 28, 2009
Clinical experts or methodologists to write clinical guidelines?Jack Hirsh, Gordon Guyatt
Journal of Thrombosis and Haemostasis : JTH|February 8, 2026
From bench to bedside: the untold story behind the clinical development of enoxaparinJack Hirsh, Noel Chan
Expert Review of Cardiovascular Therapy|October 14, 2023
Unresolved issues in the use of direct acting oral anticoagulantsNoel Chan, Jack Hirsh
Chest|December 12, 2003
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgeryGary E Raskob, Jack Hirsh
Thrombosis and Haemostasis|November 3, 2006
Monitoring unfractionated heparin with the aPTT: time for a fresh lookJohn W Eikelboom, Jack Hirsh
The American Journal of Geriatric Cardiology|June 21, 2001
Anticoagulation of the Elderly PatientShannon M. Bates, Jack Hirsh
The New England Journal of Medicine|February 15, 2018
Edoxaban for the Treatment of Venous Thromboembolism in Patients with CancerJack Hirsh, Jeffrey S Ginsberg
Archives of Internal Medicine|October 27, 2004
Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studiesJack Hirsh, Deepak L Bhatt
Archives of Internal Medicine|December 3, 2002
Is impaired renal function a contraindication to the use of low-molecular-weight heparin?Jeff Nagge, Mark Crowther, Jack Hirsh
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
Archives of Internal Medicine|October 20, 2017
Heparin Side Effects-ReplyRussell Hull, Jack Hirsh
Lancet (London, England)|April 28, 2009
Clinical experts or methodologists to write clinical guidelines?Jack Hirsh, Gordon Guyatt
Journal of Thrombosis and Haemostasis : JTH|February 8, 2026
From bench to bedside: the untold story behind the clinical development of enoxaparinJack Hirsh, Noel Chan
Expert Review of Cardiovascular Therapy|October 14, 2023
Unresolved issues in the use of direct acting oral anticoagulantsNoel Chan, Jack Hirsh
Chest|December 12, 2003
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgeryGary E Raskob, Jack Hirsh
Thrombosis and Haemostasis|November 3, 2006
Monitoring unfractionated heparin with the aPTT: time for a fresh lookJohn W Eikelboom, Jack Hirsh
The American Journal of Geriatric Cardiology|June 21, 2001
Anticoagulation of the Elderly PatientShannon M. Bates, Jack Hirsh
The New England Journal of Medicine|February 15, 2018
Edoxaban for the Treatment of Venous Thromboembolism in Patients with CancerJack Hirsh, Jeffrey S Ginsberg
Archives of Internal Medicine|October 27, 2004
Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studiesJack Hirsh, Deepak L Bhatt
Archives of Internal Medicine|December 3, 2002
Is impaired renal function a contraindication to the use of low-molecular-weight heparin?Jeff Nagge, Mark Crowther, Jack Hirsh
Pageof 13